Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.
暂无分享,去创建一个
[1] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[2] Yoshiyuki Suzuki,et al. Point mutations in the upstream region of the α-galactosidase A gene exon 6 in an atypical variant of Fabry disease , 1992, Human Genetics.
[3] S. D. Fraser,et al. The RNA binding protein YB‐1 binds A/C‐rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 , 2001, The EMBO journal.
[4] Michael Q. Zhang,et al. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes , 2001, Nature Genetics.
[5] B. Blencowe. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.
[6] C. Eng,et al. Twenty Novel Mutations in the α-Galactosidase A Gene Causing Fabry Disease , 1999, Molecular medicine.
[7] Sara G. Becker-Catania,et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.
[8] P. Sharp,et al. The SRm160/300 splicing coactivator is required for exon-enhancer function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Poenaru,et al. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches. , 1999, Biochemical and biophysical research communications.
[10] Satoshi Ishii,et al. Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor , 1999, Nature Medicine.
[11] H. Osaka,et al. Novel acceptor splice site mutation in the invariant AG of intron 6 of α‐galactosidase A gene, causing Fabry disease , 1998 .
[12] H. Osaka,et al. Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online. , 1998, Human mutation.
[13] C. Eng,et al. Fabry Disease: Thirty-Five Mutations in the α-Galactosidase A Gene in Patients with Classic and Variant Phenotypes , 1997, Molecular medicine.
[14] A. Kahn,et al. Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the α-galactosidase A gene and detection of carriers in Fabry disease , 1996, Human Genetics.
[15] S. Ishii,et al. Two novel mutations in the α-galactosidase gene in Japanese classical hemizygotes with Fabry disease , 1996, Japanese Journal of Human Genetics.
[16] R. Schwartz. An atypical variant of Fabry's disease in men with left ventricular hypertrophy , 1996 .
[17] P. Grabowski,et al. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. , 1995, RNA.
[18] T. Maniatis,et al. Synergistic interactions between two distinct elements of a regulated splicing enhancer. , 1995, Genes & development.
[19] S. Ishii,et al. Human alpha-galactosidase gene expression: significance of two peptide regions encoded by exons 1-2 and 6. , 1994, Biochimica et biophysica acta.
[20] G. Adema,et al. Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA , 1994, Molecular and cellular biology.
[21] R Kase,et al. Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease. , 1993, Biochemical and biophysical research communications.
[22] C. Eng,et al. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. , 1993, American journal of human genetics.
[23] T. Kaminuma,et al. Quantitative analysis of dystrophin gene amplification products using a PC-based image analysis system. , 1993, International journal of bio-medical computing.
[24] C. Eng,et al. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease. , 1992, Genomics.
[25] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[26] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[27] R Kole,et al. Selection of splice sites in pre-mRNAs with short internal exons , 1991, Molecular and cellular biology.
[28] B. S. Baker,et al. Regulation of doublesex pre-mRNA processing occurs by 3'-splice site activation. , 1991, Genes & development.
[29] T. Miyawaki,et al. A 3′ splice site consensus sequence mutation in the intron 3 of the α-galactosidase a gene in a patient with Fabry disease , 1991, Japanese Journal of Human Genetics.
[30] C. Eng,et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. , 1991, The New England journal of medicine.
[31] C. Obie,et al. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Desnick,et al. Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. , 1990, American journal of human genetics.
[33] K. Nagashima,et al. Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease. , 1990, Human pathology.
[34] Y. Kaneda,et al. A case of Fabry's disease in a patient with no α‐galactosidase A activity caused by a single amino acid substitution of Pro‐40 by Ser , 1990, FEBS letters.
[35] M. Becker‐André,et al. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). , 1989, Nucleic acids research.
[36] R. Desnick,et al. Nucleotide sequence of the human a-galactosidase A gene , 1989 .
[37] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[38] P. Sharp,et al. Splicing of messenger RNA precursors. , 1987, Science.
[39] P. Sharp,et al. Splicing of messenger RNA precursors. , 1987, Annual Review of Biochemistry.
[40] M. Aebi,et al. Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA , 1986, Cell.
[41] Tom Maniatis,et al. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes , 1983, Nature.